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Direct lineage reprogramming is a promising
approach for human disease modeling and regen-
erative medicine, with poorly understood mecha-
nisms. Here, we reveal a hierarchical mechanism in
the direct conversion of fibroblasts into induced
neuronal (iN) cells mediated by the transcription
factors Ascl1, Brn2, and Myt1l. Ascl1 acts as an
‘‘on-target’’ pioneer factor by immediately occu-
pying most cognate genomic sites in fibroblasts. In
contrast, Brn2 and Myt1l do not access fibroblast
chromatin productively on their own; instead, Ascl1
recruits Brn2 to Ascl1 sites genome wide. A unique
trivalent chromatin signature in the host cells pre-
dicts the permissiveness for Ascl1 pioneering activity
among different cell types. Finally, we identified
Zfp238 as a key Ascl1 target gene that can partially
substitute for Ascl1 during iN cell reprogramming.
Thus, a precise match between pioneer factors and
the chromatin context at key target genes is determi-
native for transdifferentiation to neurons and likely
other cell types.
INTRODUCTION
The lineage identity of differentiated somatic cells is considered
to be very stable because of rigid chromatin configurations,
inheritable DNA modifications, and re-enforcing transcriptionfactor networks (Vierbuchen and Wernig, 2012). However,
various experimental conditions, including nuclear transfer into
oocytes, cell fusion, and overexpression of transcription factors,
have been shown to overcome these epigenetic barriers and
induce cell-fate reprogramming to both pluripotency and unre-
lated somatic cell fates (Graf and Enver, 2009; Jaenisch and
Young, 2008; Vierbuchen and Wernig, 2011). We recently
discovered that three neuronal transcription factors Ascl1,
Brn2, and Myt1l (BAM factors) are sufficient to convert meso-
dermal fibroblasts or endodermal hepatocytes into fully func-
tional neuronal cells, termed induced neuronal (iN) cells (Marro
et al., 2011; Vierbuchen et al., 2010). The generation of human
iN cells is much less efficient and requires additional factors,
such as NeuroD1 or microRNAs (Ambasudhan et al., 2011;
Pang et al., 2011; Qiang et al., 2011; Yoo et al., 2011).
Our previous findings suggested that of the three factors,
Ascl1 is the central driver of reprogramming because only
Ascl1 is sufficient to induce immature iN cells in mouse embry-
onic fibroblasts (MEFs). In contrast, neither Brn2 nor Myt1l alone
achieve any morphological changes in MEFs. However, when
combined with Ascl1, Brn2 and Myt1l greatly improved the con-
version efficiency and both were required for the induction of
fully reprogrammed iN cells. Ascl1 is a well-studied proneural
gene of the basic helix-loop-helix (bHLH) family of transcription
factors that specifically bind DNA sequences containing an
E-box motif (Bertrand et al., 2002). It is prominently expressed
in a subset of central and peripheral neural progenitors
(Guillemot et al., 1993; Lo et al., 1991). Overexpression of
Ascl1 and related factors in the developing spinal cord induces
rapid neuronal differentiation (Ma et al., 1999; Nakada et al.,
2004). Accordingly, Ascl1 mutant mice show severe defects inCell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc. 621
neurogenesis (Guillemot et al., 1993). Ascl1 regulates and is
regulated by the Notch pathway, which mediates lateral inhibi-
tion (Bertrand et al., 2002; Guillemot et al., 1993).
The other two iN cell factors are less well characterized. Brn2
(also known as Pou3f2) belongs to the Pou-Homeodomain family
of transcription factors. Brn2 is expressed in ventricular zone
progenitor cells throughout the neuraxis and downregulated
upon differentiation, except in cortical development, where it re-
mains expressed in layer II/III and V pyramidal neurons (Domi-
nguez et al., 2012). Combined deletion of Brn1 and Brn2 in
mice resulted in severe proliferation defects of cortical progeni-
tor cells andmigration defects of upper-layer neurons, ultimately
leading to a disorganized and thinned cortex (Sugitani et al.,
2002). Very little is known about Myt1l. It contains multiple zinc
finger domains of the Cys-Cys-His-Cys (C2HC) type that are
thought to interact with DNA (Kim and Hudson, 1992). Myt1l is
expressed throughout the central and peripheral nervous system
in early postmitotic neurons (Cahoy et al., 2008; Weiner and
Chun, 1997). Interestingly, the Xenopus ortholog of Myt1 family
transcription factors X-Myt1 is required for proper neuronal dif-
ferentiation and synergizes with proneural bHLH transcription
factors to promote ectopic neurogenesis in nonneural ectoderm
(Bellefroid et al., 1996).
These observations argue that the three iN cell reprogramming
factors promote neuronal differentiation in the context of a neural
progenitor cell. It is, however, completely unclear how these fac-
tors can exert their proper function in distantly related cell types,
such as fibroblasts. Both the chromatin configuration at neuronal
genes and the expression of transcriptional coregulators are
assumed to be unfavorable for neuronal induction because
fibroblasts normally never give rise to neurons and the reprog-
ramming factors were not evolutionarily selected to induce
transdifferentiation.
Here, we used an integrative genomic approach to charac-
terize the molecular mechanism governing the early phase of
MEF-to-iN cell reprogramming.
RESULTS
BAM Factors Induce Rapid and Global Transcriptional
Changes in Fibroblasts
To begin to elucidate themolecular mechanism underlying iN cell
reprogramming, we have determined the genome-wide tran-
scriptional changes by RNA sequencing (RNA-seq) at various
time points of reprogramming (Figure 1A). In addition to control
cells infected with rtTA virus and treated with doxycycline (dox),
we have profiledMEFs 0and 48 hr after the induction of the single
or combined BAM factors with dox, as well as TauEGFP-FACS-
sorted early and late iN cells, day 13 and 22 after dox, respec-
tively. We observed that 2,522 genes significantly changed
expression over this time course (fold change > 2, p value <
0.05) (Figure 1B; Figures S2A and S2B available online). Genes
that increased expression were enriched for gene ontology
(GO) terms associated with neuronal activity (Figure 1C).
We observed that many more genes were upregulated than
downregulated at 48 hr when MEFs were infected with Ascl1
or all three factors, whereas Brn2 and Myt1l had subtle tran-
scriptional effects when expressed alone (Figures 1B and 7A).622 Cell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc.Principal component analysis (PCA) showed that Ascl1 uniquely
underlies the top two principle components of gene expression
in MEFs transduced with the BAM factors (Figure S1C). These
data suggest that Ascl1 functions mainly as a transcriptional
activator as had been proposed before (Castro and Guillemot,
2011) and that Ascl1 may be the strongest driver of the neuronal
transcriptional program.
Genome-wide Maps of BAM Factor Occupancy Reveal
Ascl1-Dominant Targeting Capacity
Based on the extensive changes in transcription observed 48 hr
after initiation of reprogramming, we performed chromatin
immunoprecipitation followed by high-throughput sequencing
(ChIP-seq) for all three BAM factors in MEFs 48 hr after induction
of all three factors. We readily identified 5,902 significant Ascl1-
occupied loci upon filtering high-quality peaks based on at least
20-fold enrichment and less than 5% FDR (Figure 2A). In
contrast, Brn2 and Myt1l ChIP-seq required substantial tech-
nical optimization (see Experimental Procedures; Figures S2B
and S2C). Under optimized conditions, Brn2 ChIP-seq revealed
2,354 peaks with at least 5-fold enrichment and less than 5%
FDR. Using the same criteria, Myt1l ChIP-seq showed only min-
imal occupancy, despite extensive crosslinking and sonication
optimization and use of different epitope tagging strategies. After
optimization, we identified 475 peaks with at least 2-fold enrich-
ment and less than 5% FDR. Most of these putative Myt1l iso-
lated sites colocalized with histone modifications associated
with accessible chromatin (Figure S2C). We confirmed that
overexpressed Myt1l is present in fibroblast nuclei by immuno-
fluorescence and in the chromatin fraction bywestern blot. How-
ever, the relative abundance of Myt1l on chromatin was less
than Ascl1 (Figure S2A).
Ascl1 Binds Similar Genomic Sites in Fibroblasts and
Neural Progenitor Cells Independent of Brn2 and Myt1l
Given the apparent dominant role of Ascl1, we next asked
whether the other two reprogramming factors are required for
Ascl1 to access its genomic targets in fibroblasts. We deter-
mined the Ascl1 binding sites by ChIP-seq in MEFs 48 hr after
infection with Ascl1 alone. Surprisingly, the pattern of binding
was virtually identical to Ascl1 binding in the context of all three
transcription factors, as the correlation was almost identical to
that observed between two biological replicates of Ascl1 ChIP-
seq in BAM infected MEFs (0.8) (Figures 3A and S3B). We
confirmed these findings by performing Ascl1 ChIP-qPCR with
cells expressing Ascl1 alone, in combination with Brn2 or
Myt1l, and with cells expressing all three factors (Figure 3E).
Thus, exogenous Ascl1 can access its binding sites in fibroblasts
without assistance from Brn2 or Myt1l.
To better characterize the nature of Ascl1 target sites in MEFs,
we sought to determine its targets in a close to physiological
context. During normal development, Ascl1 is expressed in a
subset of neural precursor cells (NPCs) of the ventricular zone
of the neural tube and is believed to instruct neuronal differentia-
tion (Guillemot et al., 1993; Lo et al., 1991). When overexpressed
in the neural tube or cultured NPCs Ascl1 induces a rapid exit
from the cell cycle and neuronal differentiation (Nakada et al.,
2004). We therefore determined the Ascl1 binding sites by
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Figure 1. Global Transcriptional Responses to the BAM Reprogramming Factors
(A) Schematic representation of the overall experimental design of this study.
(B) Hierarchical clustering and heatmap of genome-wide expression analysis during the iN cell reprogramming process by RNA-seq across indicated time points
(n = 2 biological replicates, except n = 1 for MEF+Brn2 and MEF+Myt1l). The day 13 and day 22 samples were FACS-purified for TauEGFP-positive cells. Shown
are those 2,522 genes that changed expression at least 2-fold at any time point. This emphasizes the global changes between MEFs and mature iN cells.
Compare to Figure 7A, which shows a subset of the same data, emphasizing the short-term transcriptional effect. Fold change is represented in logarithmic scale
normalized to themean expression value of a gene across all samples. Right: Names of selected genes significantly induced and repressed upon reprogramming.
(C) Top five most significant gene ontology (GO) terms enriched in the group of induced and repressed genes.
See also Figure S1.ChIP-seq in NPCswith or without overexpressing Ascl1 for 18 hr.
Unexpectedly, the comparison of those results to genome-wide
binding site analysis of Ascl1 inMEFs revealed ahighly similar oc-
cupancywith comparable affinity (Figures3A, 3C, andS3A–S3C).
As has been observed in genome-wide localization studies for
Ascl1 and other bHLH transcription factors, the E-box motif
CANNTG was highly enriched across its binding sites based
on the MEME algorithm (Figure 3B) (Bailey et al., 2009). The
CAGCTGmotif was by far themost frequently bound E-boxmotif
as seen for myogenic factor MyoD but surprisingly less so for the
other proneural bHLH factor NeuroD2 (Fong et al., 2012). Weobserved the largest fraction of binding sites in the body of genes
(often intronic sequences) followed by intergenic and promoter
regions (Figure 2B). Many of the genes that are bound by Ascl1
are members of the Notch pathway like Hes6, Dll1, and Mfng
or are otherwise associated with neural development, such as
NeuroD4 (Figure 3D).
Brn2 Is Mislocalized during the Early Stages of the
Reprogramming
To better characterize the genomic sites bound by Brn2 in BAM-
infected MEFs, we also determined the Brn2 target sites inCell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc. 623
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Figure 2. Genome-wide Maps of BAM Factors Occupancy Reveal Ascl1-Dominant Targeting Capacity
(A) Heatmaps of normalized tag densities in log2 scale, representing genome-wide occupancy profile for Ascl1, Brn2, and Myt1l in MEFs 48 hr after induction of
the BAM factors. For each bound site, the signal is displayed within a 4 kb window centered around the peak summit. Peaks are sorted based on intensity. The
signal at the corresponding genomic regions of the transcription factor binding is displayed across the other two data sets. Note little enrichment of Brn2 and
Myt1l at Ascl1 bound sites; however, strong enrichment occurs for Ascl1 in Brn2 sites, and some enrichment occurs in Myt1l.
(B) Left: Average signal intensity of Ascl1, Brn2, and Myt1l ChIP-seq peaks at respective target sites represented as the average of log2 normalized reads. Right:
Ascl1, Brn2, andMyt1l high confidence peaks genomic classification from ChIP-seq in BAM-infectedMEFs. The intensity of the shademoves clockwise, starting
with the darkest shade, which corresponds to the order of the legend (from top to bottom).
(C) BAM factors occupancy profile at the Zfp238 locus, revealing strong binding of Ascl1, but not Brn2 or Myt1l. The y axis represents the total number of mapped
reads. The genomic scale is in kilobases (kb).
See also Figure S2.cultured NPCs by ChIP-seq (Figure 4A). In contrast to Ascl1 tar-
gets, we found little overlap between Brn2 binding in fibroblasts
and NPCs (Figures 4B and 4C). A POU-like motif was signifi-
cantly enriched at Brn2 target sites in NPCs, but not in Brn2-
bound sites in BAM-infected MEFs. Instead, an E-box motif
was significantly enriched in a large fraction of these sites (Fig-
ure 4A). Direct comparison of Brn2 and Ascl1 targets in BAM-in-
fectedMEFs confirmed a high degree of overlap (Figure 2A). This
finding raises the possibility that Ascl1 actively recruits Brn2 to
some of its targets. To test this hypothesis, we performed Brn2
ChIP-seq in MEFs infected with Brn2 alone. Surprisingly, there
was hardly any overlap with either Brn2 binding in NPCs or
BAM-infected MEFs (Figures 4A–4C). About 600 (i.e., 22.2%)
of the statistically significant Brn2 targets in BAM-infected
MEFs are also significant Ascl1 targets (Figure 4D). Only 29 of624 Cell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc.these 600 sites (equivalent to 0.7% of all Brn2 targets in
MEFs+Brn2) remain Brn2-bound when Brn2 is expressed alone
(Figures 4D and S4A). These results show that Ascl1 recruits
Brn2 tomany of its targets.We have confirmed the colocalization
of Brn2 and Ascl1 on the fibroblast chromatin by reciprocal
coimmunoprecipitation experiments. Chromatin immunoprecip-
itated with antibodies against Brn2 contained a substantial
amount of Ascl1 in MEFs infected with both factors (Figure 4E,
middle panel). Consistent with the ChIP-seq data, chromatin
pulled down with Ascl1 antibodies contained relatively less
Brn2 (Figure 4E, right panel). To define the window of Brn2 action
during iN reprogramming, we generated Ascl1-inducible MEFs
and infected them with Brn2 1 day before or 2 or 5 days after
addition of dox. The neuronal complexity, measured as total
neurite length, increased about 6-fold when Brn2 was added at
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Figure 3. Ascl1 Binds Similar Genomic Sites in Fibroblasts and Neural Progenitor Cells Independent of Brn2 and Myt1l
(A) Heatmaps of normalized tag densities, representing a genome-wide occupancy profile for Ascl1 across cell samples: MEFs infected with Ascl1, 48 hr
postinduction (MEFs+Ascl1), MEFs infected with the BAM factors, 48 hr postinduction (MEFs+BAM), and NPCs infected with Ascl1, 18 hr postinduction (NPCs).
For each bound site, the signal is displayed within a 4 kb window centered around the peaks.
(B) The E-box motif is significantly enriched at Ascl1 target sites across data sets (p value 5.9e1353).
(C) Average signal intensity of Ascl1 high confidence peaks across the three cell types as defined in (A), represented as the average of normalized reads in
log2 scale.
(D) Representative tracks comparing Ascl1 occupancy at two neuronal target genes across the three cell types.
(E) Ascl1 ChIP-qPCR at selected neuronal target genes in MEFs 48 hr after induction of Ascl1 alone or in combination with the indicated transcription factors.
Target gene binding by Ascl1 is not greatly influenced by the presence of Brn2 or Myt1l. Error bars = standard deviation of the DCT.
See also Figure S3.days1 and 2 and about 2-fold when added at day 5 (Figures 4F
and S4B). In summary, these data suggest that the vast majority
of Brn2-bound sites in MEFs are nonphysiological, and in part
Brn2 gains access to chromatin sites made accessible by
Ascl1. Furthermore, they suggest that Brn2 is primarily needed
for later stages of reprogramming by contributing to iN matura-
tion even up to 5 days after initiation of iN reprogramming.Unlike Brn2, Ascl1 Acts as a Pioneer Factor in
Fibroblasts
The surprising discovery that Ascl1 binds similar target sites in
BAM-infected MEFs as in NPCs raised the question of whether
those genomic Ascl1 target sites are in an open (nucleosome-
free) or closed (nucleosome-bound) state in fibroblasts before
infection. Based on the crystal structure of MyoD, bHLHCell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc. 625
Figure 4. Brn2 Is Mislocalized during the Early Stages of the Reprogramming
(A) Heatmaps of normalized tag densities representing genome-wide occupancy profile for Brn2ChIP-seq inMEFs+Brn2 alone,MEFs+BAM, andNPCs. For each
bound site, the signal is displayed within a 4 kb window centered around the summits of binding sites. Bottom panel illustrates themost significant motif enriched
at Brn2 binding sites in MEFs+BAM (left, an Ascl1 motif, p = 3.3e524) and in NPCs (right, a Brn2 motif, p = 3.9e472). No significant motif was enriched in the
MEFs+Brn2 data set.
(B) Venn diagram representing Brn2 high confidence peak overlap between targets in MEFs+Brn2, MEFs+BAM, and NPCs.
(C) Representative tracks illustrating Brn2 occupancy profile in MEFs+BAM and NPCs, and Ascl1 occupancy in MEFs+BAM. Top, middle, and bottom panels
depict examples corresponding to 67.5%, 5.5%, and 27% of the cases observed for Brn2 occupancy between data sets, respectively.
(legend continued on next page)
626 Cell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc.
transcription factors are predicted to only be able to bind
nucleosome-free DNA (Ma et al., 1994). To measure the nonnu-
cleosomal fractions of theMEFgenome,weperformed formalde-
hyde-assisted isolation of regulatory elements followed by high
throughput sequencing (FAIRE-seq) in uninfected MEFs (Giresi
et al., 2007). Strikingly, the FAIRE analysis showed that Ascl1
target sites in MEFs were on average substantially depleted of
nucleosome-free DNA (Figure 5A). These results demonstrate
that Ascl1 preferentially binds previously closed chromatin in
MEFs as early as within 48 hr and thus fulfills the formal criteria
of a pioneer transcription factor (Zaret and Carroll, 2011).
To gain insight into the differential binding behaviors of Ascl1
and Brn2, we plotted the FAIRE signal from uninfected MEFs
at the genomic sites bound by Brn2 in BAM-infected MEFs.
We found that, in contrast to Ascl1, Brn2 targets sites in
MEFs are predominantly nucleosome free (Figure 5A). We next
sought to characterize the histone marks associated with Brn2
targeting in fibroblasts. We generated H3K27ac ChIP-seq data
in MEFs and utilized previously published ChIP-seq data sets
for the H3K4me1, H3K4me3, and H3K27me3 histone marks.
Consistent with our observation that Brn2 mostly binds acces-
sible chromatin, Brn2 bound sites in fibroblasts are enriched for
‘‘active’’ marks, such as H3K4me1, H3K4me3, and H3K27ac
(Figure 5B). The chromatin configurations of the Myt1l targets
are also associated with open and active chromatin as demon-
strated by the significant enrichment for the ‘‘active’’ marks
H3K4me3 and H3K27ac at the 475 high-confidence bound sites
(Figures 2A, 2B, and 5C).
Given that, unlike Ascl1, Brn2 does not act as a pioneer factor,
we then wondered whether the proper Brn2 targets in NPCs are
perhaps closed inMEFs, whichwould explain why Brn2 is barred
from binding there. Surprisingly, we found that, similar to the
observed Brn2-bound sites in MEFs, the Brn2-target sites in
NPCs are quite open in MEFs, although to a slightly lesser
degree than in the factual binding sites in MEFs (Figure 5D). As
expected, the Ascl1 targets in NPCs are in a preferentially
closed state in MEFs (Figures 5D and S5A). Thus, nucleosome
occupancy is neither predictive for Ascl1 nor for Brn2 binding
in MEFs.
A ‘‘Trivalent’’ Chromatin State Predicts Accessibility of
Ascl1 and Permissiveness for iN Cell Reprogramming
among Different Cell Types
Pioneer factors can access nucleosomal DNA, yet only a very
small proportion of all binding sites present in the genome are
actually bound by any given transcription factor. Furthermore,
transcription factors (including the well-characterized FoxA(D) In MEFs+BAM, 22.2% of Brn2 sites colocalize with Asc11, a significant differ
Asc11. Only 0.7% of Brn2 peaks in theMEFs+Brn2 data set overlap with Ascl1 tar
overlap between high confidence peaks.
(E) Chromatin coimmunoprecipitation (co-IP) of Brn2 in MEFs infected with Brn2
Brn2+Ascl1 cells (right). IPs were probed with antibodies against Brn2 (upper
chromatin is precipitated with Brn2 or Ascl1 antibodies, respectively, demonstra
(F) Brn2 contributes to neuronal maturation. Representative Tuj1 staining 11 days
with Brn2 at different stages. From left to right the images show (1) negative con
control infected with Brn2 1 day before dox induction, and (3 and 4) infected with B
maturation even up to 5 days after initiation of iN reprogramming.
See also Figure S4.pioneer factors) bind different sets of target sites depending on
the cellular context (Zaret and Carroll, 2011). Thus, additional
parameters must exist that determine selective binding. We
sought to explore whether a specific signature of pre-existing
histone marks in MEFs is associated with Ascl1 target sites.
Average enrichments values of the individual marks showed
strong enrichment of H3K4me1, H3K27acetyl, and H3K9me3
at Ascl1 target sites based on binding in NPCs. In contrast,
none of those histone marks were significantly enriched in
MEFs at the sites in which Brn2 is bound in NPCs (Figure 6A).
We next devised a strategy to locate and quantify the triva-
lent chromatin state comprised of H3K4me1, H3K27ac, and
H3K9me3.Wewished to confirm the co-occurrence of these his-
tone modifications in an unbiased manner because in particular
the repressive mark H3K9me3 may not be expected to coexist
with the active enhancer marks H3K4me1 and H3K27ac. We
adapted a previously described Hidden Markov Model analysis
tool ChromHMM (Ernst and Kellis, 2012). ChromHMM was
used to define unique combinations of chromatin marks
genome-wide in MEFs based on the five available histone mod-
ifications, and we then calculated the enrichment of each of
these states in a set of user-specified genomic sites (Ernst and
Kellis, 2012). This analysis revealed a specific MEF chromatin
state (ChromHMM state 5) that is enriched at Ascl1 binding sites
(Figure 6B). ChromHMM state 5 in MEFs represents the combi-
nation of high enrichment values for H3K4me1 andH3K27ac and
low-to-intermediate enrichment levels of H3K9me3, which were
also the three histone marks that showed a significant enrich-
ment when averaged across all Ascl1 binding sites (in the
following also referred to as ‘‘trivalent chromatin state’’) (Fig-
ure 6B). Notably, the presence of H3K9me3 has been previously
identified as ‘‘poised’’ enhancer mark with cell-type-specific
control of enhancer activity (Zentner et al., 2011; Zhu et al.,
2012). Among MEFs, NPCs, human fibroblasts, and keratino-
cytes, this trivalent state ranges from 0.34%–1.7% of the
genome. Of all HMM chromatin states, state 5 showed the high-
est enrichment at Ascl1 targets (Figures S6A, S6B, S6H, and
S6I). Sequential immunoprecipitation of mononucleosomes iso-
lated from MEFs demonstrated the co-occurrence of the three
chromatin states H3K27ac, H3K4me1, and H3K9me3 on single
nucleosomes, validating the existence of the trivalent state
(Figure S6C).
Although the genome-wide Ascl1 occupancy is highly similar
in MEFs and NPCs, there is a small fraction of sites bound by
Ascl1 in NPCs that are not bound in MEFs. Remarkably, those
sites have about 2-fold lower enrichment for the trivalent chro-
matin state (Figure S6D). This finding is yet more correlativeence (p < 0.0001 t test) to only 9.9% of Brn2 sites in NPC that colocalize with
get sites inMEFs+BAM. Peak overlap was determined by at least one base pair
(left) or Brn2+Ascl1 (middle). Chromatin co-IP of Ascl1 in MEFs infected with
row) or Ascl1 (bottom row). Both Ascl1 and Brn2 protein is detectable when
ting co-occupancy of the two factors on chromatin.
after dox-induction in the VA1 cell line (containing dox-inducible Ascl1) infected
trol (infected with GFP to control for possible virus toxicity effects), (2) positive
rn2 2 days and 5 days, respectively, after dox induction. Brn2 contributes to iN
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Figure 5. Ascl1, but Not Brn2 and Myt1l, Acts as a Pioneer Factor in Embryonic Fibroblasts
(A) Average FAIRE-seq signal of uninfected MEFs at Ascl1 and Brn2 target sites in MEFs infected with the BAM factors. For each target site, the signal is
displayed ± 250 bp from the peak summit. Whereas Brn2 targets are mostly nucleosome free, the Ascl1 targets are predominantly nucleosome bound in MEFs.
(B) Left: Average enrichment of individual histone marks in MEFs, based on Brn2 target sites in MEFs after infection with the BAM factors. Right: Heatmaps of
normalized tag densities representing MEFs chromatin marks at the same Brn2 targets sites. The signal is displayed within an 8 kb window centered around the
binding sites.
(C) Left: Average enrichment of individual histone marks in MEFs, based on Myt1l target sites in MEFs infected with BAM. Right: Heatmaps of tag densities
representing indicated histone marks at Myt1l targets sites. The signal is displayed within an 8 kb window centered around the binding sites.
(D) Average FAIRE-seq signal of uninfected MEFs at the genomic sites at which Ascl1 (blue) or Brn2 (purple) is bound in NPCs. Dotted line represents the FAIRE-
seq signal at random sites.
See also Figure S5.
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evidence that the trivalent chromatin state may favor access of
Ascl1 to its target sites.
To address this hypothesis experimentally, we asked whether
the presence of a trivalent chromatin state could predict Ascl1
binding in other cell types. We first calculated the enrichment
for histone signatures at putative Ascl1 binding sites across
distinct cell types, for which iN cell reprogramming efficiency
was known, based on Ascl1 targets in NPCs. At Ascl1 targets,
our analysis predicts enrichment for a trivalent chromatin state
in MEFs and human dermal fibroblasts (NHDF). Conversely, it
predicts low levels in normal human keratinocytes (NHEK) (Fig-
ure 6C). Therefore, we tested whether Ascl1 can access its
cognate sites in human dermal fibroblast versus keratinocytes.
Indeed, 48 hr after induction, the binding of Ascl1 to its predicted
target sites was much higher in fibroblasts than in keratinocytes
as determined by ChIP-qPCR, despite equivalent Ascl1 expres-
sion and IP efficiencies (Figure 6E). To verify these results in a
global manner, we mapped Ascl1’s genome-wide target sites in
NHDF and NHEK cells ectopically expressing Ascl1 by ChIP-
seq (Figure 6D). As predicted by the trivalent state model, Ascl1
occupancy in NHDF is significantly enriched for the canonical
Ascl1 E-box, indicating that it is on target. In contrast, in NHEK
cells in which Ascl1 sites lack the trivalent chromatin state,
Ascl1 occupied almost completely different, off-target sites that
lacked the motif. Only about 5.3% of the most confident Ascl1-
bound sites in NHEK contained an E-box motif when a de novo
motif search was conducted. In accordance with these results,
we have failed thus far to convert keratinocytes into iN cells using
transcription factor combinations containing Ascl1, whereas
fibroblasts and hepatocytes can be reprogrammed efficiently
(Marro et al., 2011; Pang et al., 2011; Vierbuchen et al., 2010).
We extended our analysis to make predictions for nine addi-
tional human cell types for which there were publicly available
data for the same five chromatin marks (Figure 6F). We used
ChromHMM software to define chromatin states in each cell
type and then calculated the enrichment for the trivalent state at
predictedAscl1 target sites.We found that humanskeletalmuscle
myoblasts havestrongenrichment for the trivalent chromatin state
at Ascl1 sites, whereas human osteoblasts showed low levels.
Consistentwithourpredictions,humanskeletalmusclemyoblasts
are reprogrammed with efficiencies similar to reprogramming
human fibroblasts when transduced with Ascl1, Brn2, Myt1l,
and NeuroD1 (Pang et al., 2011), whereas only very few iN cells
formed from infectedosteoblasts (Figures 6GandS6E). The ability
topredict reprogrammingacross cell types of previously unknown
potential provides strong support for the importance of the
trivalent chromatin state in Ascl1-mediated reprogramming.
Conversely, experimental disruption of the trivalent state
correlated with impaired MEF reprogramming to iN cells. We ex-
pressed JmjD2d, a histone demethylase that ‘‘erases’’ H3K9me3
or a catalytically inactive point mutant JmjD2d (H189A) (Krishnan
and Trievel, 2013; Shi and Whetstine, 2007; Whetstine et al.,
2006; Zhu et al., 2012) in MEFs 2 days before Ascl1 infection.
JmJD2d overexpression resulted in substantial demethylation
and reduction of iN cells formed after 2 weeks (Figure 6H). The
reduction of reprogramming may also be explained by other
effects of JmjD2d. Finally, H3K9me3 can undergo further dy-
namic changes during iN reprogramming (Figures S6F and S6G).Ascl1 Target Genes Are Preferentially Induced during
Reprogramming, Unlike Brn2 Target Genes
Next, we wanted to explore the possible downstream mecha-
nisms thatmediate iN cell reprogramming initiated by expression
of the BAM factors. To accomplish this, we first correlated Ascl1
binding with transcriptional changes. Compatible with the pre-
vailing notion that Ascl1 acts primarily as transcriptional acti-
vator, we found that most Ascl1 target genes are upregulated
48 hr after dox (Figures 7A and S7A). Of the 790 genes that signif-
icantly change expression by 48 hr, 143 genes are bound by
Ascl1, and 133 of those are induced. In contrast, we did not
find a similar correlation for genes associated with Brn2 target
sites (Figure 7A). Only 42 genes of the 790 genes that change
expression were bound by Brn2 in BAM-infected MEFs. More-
over, Ascl1 does not require Brn2 or Myt1l as a cofactor to
induce its target genes, because its 1,198 target genes are highly
upregulated on average with or without coexpression of Brn2
and Myt1l at 48 hr and, importantly, remain induced throughout
the entire reprogramming process (Figure 7B). In contrast, Brn2
promotes fewer transcriptional changes with only subtle upregu-
lation of target genes (Figures 7A and 7C). In particular, we iden-
tified 454MEF-specific Brn2 targets, which tend to be transiently
induced but are eventually silenced in iN cells as well as in
cortical neurons and NPCs (Figure 7C). From the small fraction
of overlapping NPCs/MEFs Brn2 targets that actually contained
a POU-motif, we identified 87 genes that are upregulated faster,
remain expressed during reprogramming, and tend to be
expressed in cortical neurons and NPCs (Figure 7C, left panel).
Thus, most Brn2 targets show only transient expression
changes, but a small, but distinct, set of Brn2 target genes in
MEFs do contribute to long-term iN cell transcription.
iN Cell Reprogramming Is Mediated In Part by the Direct
Ascl1 Target Gene Zfp238
Integrative analysis of our transcriptional data identified 25
transcription factors that were significantly upregulated by
BAM factors and may mediate the iN cell reprogramming pro-
cess. A literature survey revealed that as many as 12 of the 25
factors potentially play important roles in neural development.
None of these 12 transcription factors could individually induce
neuronal cells or improve iN efficiency when combined with
Ascl1 (Figure 7D). However, when tested in combination with
Myt1l, 1 of the 12 factors, the Ascl1 target gene Zfp238, could
induce neuron-like cells (Figures 2C, 7E, and 7F). Although these
cells expressed the neuronal markers Tuj1 and MAP2, their
morphology appeared less mature, and the overall efficiency of
their generation was highly reduced compared with Ascl1 and
Myt1l (Figures 7E and 7F). Electrophysiological characterization
showed that Zfp238/Myt1l-iN cells had less mature passive and
active membrane properties than did Ascl1/Myt1l-iN cells (Fig-
ures 7I and 7J). A smaller fraction of Zfp238/Myt1l-iN cells could
generate single or repetitive action potentials (see pie charts in
Figure 7I). Whereas action potential thresholds and amplitudes
were similar, the total numbers of action potentials in response
to various amounts of current injections were significantly
reduced in Zfp238/Myt1l-iN cells (Figures 7Ji–Jiii). Moreover,
their resting membrane potential was depolarized, their capaci-
tance decreased, and their input resistance increased comparedCell 155, 621–635, October 24, 2013 ª2013 Elsevier Inc. 629
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Figure 6. A Trivalent Chromatin State Is Characteristic and Predictive of Ascl1 Chromatin Accessibility between Different Cell Types
(A) Average enrichment of individual histone marks in uninfected MEFs at the sites at which Ascl1 (left) or Brn2 (right) is bound in NPCs. For each binding site, the
signal is displayed ± 750 bp from peak summit.
(B) MEFs chromatin states, based on ChromHMM analysis. Heatmap of chromatin states enrichment within 2/+2 kb from Ascl1 binding site in NPCs. Arrow
highlights most differentially enriched state between Ascl1 and Brn2 binding sites specified as state #5 (trivalent chromatin state = H3K4me1, H3K27acetyl, and
H3K9me3).
(C) Average enrichment of trivalent chromatin state at predicted Ascl1-bound sites across cell types based on Ascl1 binding in NPCs (white columns). In black
columns the average enrichment for trivalent chromatin state at Ascl1-bound sites from Ascl1 ChIP-seq in MEFs, NHDF, and NHEK overexpressing cells are
represented. NHDF, normal human dermal fibroblasts; NHEK, normal human epidermal keratinocytes. Error bars = SEM.
(D) Venn diagram representing Ascl1 ChIP-seq peak overlap between targets in NHDF andNHEK cells. Bottom:Motif enriched inmost confident thousand peaks.
(E) Left: Ascl1 ChIP-qPCR at predicted Ascl1 target genes in NHDF andNHEK cells overexpressing Ascl1 reveals substantially better binding in fibroblasts than in
keratinocytes. Right: Validation of equivalent pull-down efficiency of Ascl1 in NHEK and NHDF cells by ChIP followed by immunoblotting against Ascl1. Error
bars = standard deviation of the DCT.
(F) Average enrichment of trivalent chromatin state at predicted Ascl1-bound sites based on Ascl1 binding in NPCs across Encode cell types with chromatin data
publicly available. The highest enrichment scores predicted for Ascl1-mediated reprogramming in human skeletal muscle myoblasts are in orange. One of the
lowest enrichment scores predicted for Ascl1-mediated reprogramming in human osteoblasts is in green. Error bars = SEM.
(legend continued on next page)
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to Ascl1/Myt1l-iN cells (Figures 7Jiv–Jvi). Na+ currents were not
significantly different between the two conditions (Figures S7B
and S7C). Thus, the single transcription factor Zfp238 mediates
an important component of the transcriptional output of Ascl1
together with other critical downstream factors.
In order to identify these missing regulators, we measured the
extent to which the remaining 11 candidates can improve the re-
programming of Zfp238/Myt1l-iN cells. We expressed Zfp238,
Myt1l, and each of the 11 factors separately in MEFs and found
that Lmo2, Rfx1, and Tcfl5 significantly improved the generation
of iN cells (Figures 7D, 7G, and 7H). These results suggest that
these three transcription factors act in parallel to Zfp238 and
together execute the BAM-induced program leading to iN cell
formation (Figure S7D).
DISCUSSION
‘‘On-Target’’ Pioneer Factor Activity of Ascl1
The dominant model of lineage reprogramming is transcription
factor cooperativity based on factor co-occupancy and mutual
positive feedback loops—a concept put forward based on iPS
cell reprogramming (Jaenisch and Young, 2008). In fact a recent
study confirmed this model by showing that Oct4, Sox2, Klf4,
and c-Myc cooperatively bind to a vast number of the same
enhancers in fibroblasts (Soufi et al., 2012). Three of the four fac-
tors were also shown to bind sites predominantly in a nucleo-
somal configuration and hence were regarded pioneer factors.
Importantly, though, the vast majority of binding sites were mis-
localized as the proper targets appeared to be barred by large
repressed chromatin domains enriched by H3K9me3 modifica-
tion. The observed initial mistargeting of the reprogramming
factors is a plausible explanation for the low efficiencies and
slow kinetics of iPS cell reprogramming. By analogy, it could
be assumed that other types of lineage reprogramming also
involve transcription factor cooperativity and positive feedback
activation (Vierbuchen and Wernig, 2012).
In stark contrast, our investigation of transcription factor occu-
pancy states in iN cell reprogramming has revealed a surprising
asymmetry in the behavior of the three reprogramming factors.
At the top of the hierarchy stands Ascl1, which we found could
access nucleosomal DNA and—unlike Oct4—also immediately
bound its authentic neuronal target genes across the fibroblast
genome. The term ‘‘pioneer factor’’ has been used to describe
transcription factors that can bind nucleosomal DNA as single
factors as opposed to regular transcription factors that require
cooperation (Zaret and Carroll, 2011). Here, we propose the
term ‘‘on-target pioneer factor’’ to refer to pioneer factors like
Ascl1 that bind their cognate lineage-specific targets whether
genomic sites are freely available or are nucleosome bound in
heterotypic cell types. Supported by structural models, classic(G) iN cell conversion efficiency expressed as ratio of neuronal, MAP2+ cells/seede
Myt1l, and NeuroD1. Measurements were carried out 20 days after induction of tra
two cell types (error bars = SEM, n = 3 biological replicates, **p < 0.01).
(H) Characterization of Ascl1-mediated reprogramming upon global loss of H3
JmjD2d. Left: Tuj1 staining of MEFs expressing WT or H189A JmjD2d after Ascl1
mutant (H189A) JmjD2d overexpressing MEFs. Bottom: Detection of H3K9me3
See also Figure S6.pioneer factors have been proposed to access the DNA from
one side, leaving the opposite site available for histone interac-
tion (Soufi et al., 2012; Zaret and Carroll, 2011). In contrast,
Ascl1—like any bHLH transcription factor—binds the two neigh-
boring major groves of DNA as heterodimer in a fork-like pattern
with its a-helical basic domain, excluding the possibility of simul-
taneous nucleosome binding (Ma et al., 1994). Therefore, the
mechanism of nucleosomal DNA access must be different
between pioneer factors reported to date. Assuming nucleo-
somes are not static and pioneer factors have a higher DNA
affinity than do histones, once target sites are bound, they might
be barred from histone wrapping.
MyoD, one of the earliest reprogramming factors identified, is
also a bHLH factor and was shown to create DNase-hypersensi-
tive sites at myogenic promoters and eliminate nucleosome
phasing in the Myogenin promoter in MEFs, suggesting pioneer
factor activity (Gerber et al., 1997). Whether MyoD can also act
as an ‘‘on-target’’ pioneer factor requires more investigation.
Its binding pattern in MEFs seems similar to muscle cells, but
there is only a 30% overlap between binding in MEFs and the
neurogenic P19 cell line after acute expression (Cao et al.,
2010; Fong et al., 2012).
In contrast, Brn2 and Myt1l clearly do not have pioneer factor
activity as they access mostly open chromatin and play a less
dominant role during the early stages of iN cell reprogramming.
Brn2 is predominantly localized to different sites than in NPCs.
Surprisingly, this mislocalization could not simply be explained
by differential chromatin accessibility as the ‘‘proper’’ neural
Brn2 targets were overall in an accessible state in MEFs. At least
a portion of the mislocalized targets could be explained because
Ascl1 recruited Brn2 to many of its targets.
The ‘‘on-target’’ pioneer property of Ascl1 versus ‘‘off-target’’
character of the iPS cell factorsmay verywell explain the dramat-
ically higher iN cell reprogramming efficiency of 20% within
2 weeks (Vierbuchen et al., 2010). ‘‘On-target’’ capability could
become a valuable criterion to identify the most efficient re-
programming factors to induce other cell lineages especially if
no candidate factor has reprogramming activity on its own.
Exploring whether the FoxA and GATA pioneer factors used for
hepatocyte and cardiac reprogramming are also ‘‘on-target’’ fac-
tors would be interesting (Ieda et al., 2010; Huang et al., 2011).
A Chromatin Signature Predicts Reprogramming
Capacity
Although Ascl1 acted as an on-target pioneer factor in fibro-
blasts, it did not do so in keratinocytes. Therefore, chromatin
features other than nucleosome occupancy must influence this
factor’s access to chromatin. We discovered a unique ‘‘trivalent’’
chromatin signature—comprised of H3K4me1, H3K27ac, and
H3K9me3—that predicts permissiveness for Ascl1 occupancyd cells in skeletal musclemyoblasts, and osteoblasts infectedwith Ascl1, Brn2,
nsgenes. A t test was performed to compare reprogramming efficiencies of the
K9me3 by overexpression of wild-type (WT) or catalytically mutant (H189A)
induction for 11 days. Right: Fraction of Tuj1-positive neurons in WT, relative to
levels by immunoblot. Error bars = SEM, n = 3 biological replicates.
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Figure 7. Zfp238 Is a Critical Ascl1 Target and iN Cell Reprogramming Mediator
(A) Left: Heatmap representing RNA-seq data in MEFs 48 hr after infection with the indicated factors. Genes (790) are shown that changed expression at least
2-fold in any given condition. Fold change of gene expression is represented in logarithmic scale. Of the 790 genes, 607 are upregulated in MEFs+Ascl1 versus
MEFs and 183 are downregulated. In MEFs+BAM, 143 of the 790 genes classify as Ascl1 targets, of which 133 are upregulated and ten are downregulated.
(legend continued on next page)
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and iN cell reprogramming among various nonneural cell types.
This permissive chromatin signature should be highly useful in
choosing recipient cells for neural reprogramming ex vivo or
in vivo for therapeutic purposes.
The enrichment of a repressive mark was surprising, espe-
cially in light of the recent finding that H3K9 methylation sites
are occluded for the iPS cell reprogramming factors (Soufi
et al., 2012). However, the colocalization of H3K4me1 and
H3K9me3 has been suggested as a poised state for cell-type-
specific enhancers in ESCs that are later activated, similar to
the H3K4me3 and H3K27me3 ‘‘bivalent’’ domains (Bernstein
et al., 2006; Zhu et al., 2012). Hence, the trivalent signature
described here may represent a remnant form of such early
embryonic poised states.
Although the discovery of a pre-existing defined chromatin
configuration that is associated with Ascl1 binding is intriguing,
it is also evident that this trivalent mark cannot explain all
Ascl1 binding. Presumably, nonchromatin factors, such as yet
unknown cofactors, may be expressed to different levels in
different cell types, impacting binding and transcriptional activity
of the reprogramming factors. In addition, only a small fraction of
the thousands of binding sites could be functionally relevant
and the accessibility to those sites may explain the vast majority
of the variation in reprogramming efficiencies between cell types
despite similar global responses.
A Distinct Cascade of Transcription Factors Mediating
Neuronal Reprogramming
The interplay of Ascl1 and Zfp238 and other targets is yet another
aspect of the hierarchical organization of iN cell reprogramming.
First, based on binding and transcriptional data Ascl1 is the
direct upstream activator of Zfp238. Second, Zfp238 executesRight: Ascl1, Brn2, or Myt1l targets within these 790 genes. Genes were identified
start site of genes. Data are represented as mean ± SEM.
(B) Quantification of average changes in gene expression of Ascl1 target genes i
various time points of reprogramming. (Thirteen day and 22 day samples were Ta
log2 scale) for the identified RefSeq genes. Data are represented as mean ± SEM
(C) Left: Quantification of average change in gene expression of Brn2 target gene
points (as in B and neuronal cell populations). Right: Quantification of average ch
depictedacross timepoints andneuronal cell populations. y axis represents theave
(D) Left: Expression level heatmap (log2 based) of the BAM factors and 12 sel
summarizing screen strategy and results for iN cell formation upon expression o
Zfp238 and Myt1l.
(E) Immunofluorescent detection of Tuj1 (red) and DAPI (blue) of iN cells derived
(F)Quantificationof reprogrammingefficiencybymeasuringnumberof cellswithneu
of labeled cells per 103 visual field in at least ten randomly picked fields are show
(G) Immunofluorescent detection of Tuj1 (red) and DAPI (blue) iN cells derived from
(right).
(H) Average number of Tuj1+ cells and total neurite length of MEFs expressing Zfp
and Ascl1+Myt1l (A+M) are shown. A t test was performed compared to the GFP
(I and J) Electrophysiological characterization of iN cells derived from MEFs by o
Cells patched in current-clamp mode. Action potential (AP)-generation pattern i
ulation protocol). Example traces from cells generating multiple (middle panels) o
cells firing single (green), multiple (blue), or no (yellow) action potentials (n = 18 ce
(lines) of iN cells capable of firing action potentials in Ascl1+Myt1l (n = 18 cells /
responding averages ± SE (filled circles with error bars). No significant differences
(iii) However, the number of APs fired (AP #) plottedwith respect to current pulses (
(asterisks, p < 0.02). (4) No significant differences found in resting membrane-po
nificant difference (asterisks) in capacitance (p > 0.005) (Cm,v) and membrane re
See also Figure S7.an important but only a part of the lineage-specification program
of Ascl1, as we found three additional transcription factors that
cooperate with Zfp238 to generate iN cells. Hence, out of the
thousands of target genes, only a handful appears to be critical
for neuronal reprogramming. This conclusion may be helpful to
enable reprogramming of thus far resistant cell types, such as
keratinocytes. Collectively, our results suggest that iN cell re-
programming is a powerful tool to interrogate transcription factor
function and to uncover transcriptional networks in neuronal
lineage specification.
EXPERIMENTAL PROCEDURES
Cell Derivation, Culture, and Viral Production
TauEGFP MEFs were isolated, and lentivirus was produced as previously
described (Vierbuchen et al., 2010). ES cell-derived NPCs (line NS5) were ob-
tained from A. Smith, Cambridge, UK, and cultured as previously reported
(Conti et al., 2005). To establish Ascl1-inducible MEFs, we first generated a
Rosa26 CAGGS-M2rtTA-T2A-puro ES cell line by homologous recombination
and infected this with a TetO-flagAscl1 lentivirus. A subclone showing robust
induction was then injected into blastocysts to generate chimeric embryos for
MEF isolation. More detailed information can be found in the Extended Exper-
imental Procedures.
Expression Analysis, Chromatin Immunoprecipitation,
and FAIRE-Seq
Total RNA was isolated and Poly-A selected. Libraries were prepared, and
sequencing reads (100 bp) were generated on Hi-Seq 2000 Illumina platforms.
Paired-end reads were aligned to the mouse reference sequence NCBI Build
37/mm9. Expression levels of RefSeq-annotated genes were calculated in
unit of fragments per kilobase of exon model per million mapped fragments
(FPKM). Differential expression analysis was performed using Student’s t test
function ‘‘t.test’’ in R, andgeneswith a p value < 0.05 and at least 2-fold expres-
sion change were defined as significant. Gene ontology analysis was per-
formed using DAVID (david.abcc.ncifcrf.gov). ChIP-qPCR and ChIP-seqas targets based on binding peaks within10 to +2 kb from the transcriptional
n MEFs 48 hr after BAM induction was identified in (A) and is depicted across
uEGFP sorted.) y axis represents the average expression (normalized reads in
.
s based on overlapping peaks between MEFs and NPCs, depicted across time
ange in gene expression of Brn2 target genes, based on MEF-specific peaks,
rage expression (normalized reads in log2scale) for the identifiedRefSeqgenes.
ected transcription factors induced during reprogramming. Right: Schematic
f the candidate factors alone, in combination with Myt1l, or in combination of
from MEFs after infection with Ascl1+Myt1l or Zfp238+Myt1l.
ronalmorphologyandpositive forMAP2andTuj1.Averagesof averagenumbers
n (error bars = SEM, n = 3 biological replicates, t test **p < 0.01, ***p < 0.001).
MEFs after infection with Zfp238+Myt1l and Rfx1 (left), Lmo2 (middle), or Tcfl5
238+Myt1L (Z+M) plus the indicated factor. Also, MEFs infected with Ascl1 (A)
control (error bars = SEM, n = 5 visual fields, **p < 0.01, ***p < 0.001).
verexpressing either Ascl1 (black) or Zfp238 (red) in combination with Myt1l. (I)
nduced by current pulses of stepwise-increasing amplitudes (top panel: stim-
r single (bottom panels) APs in either condition. Pie charts indicate fraction of
lls / 3 batches). (J) Cumulative plots (Cum freq) representing intrinsic properties
3 batches) and Zfp+Myt1l (n = 14 cells / 3 batches) conditions with their cor-
found in AP threshold (APthreshold, p > 0.1) (i) or AP height (APheight, p > 0.2) (ii).
I) of increasing amplitudewas significantly different between the two conditions
tential (Vrest, p > 0.05). Cumulative plots with average values ± SE show sig-
sistance (p > 0.002) (Rm, vi) measured at holding potential 70 mV.
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were carried out in Ascl1- and BAM-infected MEFs 48 hr after dox, and in un-
infected or Ascl1-infected NPCs 18 hr after induction. Cells were infected
with a pool of Ascl1, V5- or FLAG-tagged Brn2, and V5- or FLAG-tagged
Myt1l, and the transgenes were induced with dox the day after. A list of anti-
bodies used and detailed experimental procedures, including ChIP co-IP and
primary computational analysis, can be found in the Extended Experimental
Procedures. Formaldehyde-assisted isolation of regulatory elements (FAIRE-
seq) followed the previously described method (Giresi et al., 2007).
Computational Analysis
To identify chromatin states, we used the ChromHMM software (v. 1.06)
according to Ernst and Kellis (2012). A self-developed script was used to
calculate the percentage of genomic bases within a ±200 bp window at the
top 1,000 transcription factor peak summits that were occupied by the given
state. To obtain the normalized frequency of Ascl1 peaks in each state, the
total number of Ascl1 peaks in each state was divided by the length of the cor-
responding state’s segmentation size and multiplied by 1 megabases (Mb).
The principal component analysis was performed using the PCA package in
Microsoft Excel’s statistical add-in ‘‘XLSTAT.’’
Electrophysiology
Whole-cell patches were established at room temperature using manipulators
and amplifiers controlled by Clampex 10 Data Acquisition Software (Molecular
Devices). Resting membrane potential, input resistance, and capacitance
were recorded for every cell. The current clamp mode was used to record
action potentials. We set the initial resting membrane potential (Vrest)
to 60 mV using a small, constant holding current and applied current-pulses
of 10–50 pA with a step-size of 10 pA, to test the ability to generate action
potentials. Statistical comparisons between cumulative plots were made
using the K-S (Kolmogorov-Smirnov) test.
ACCESSION NUMBERS
TheGEO repository accession number for the ChIP- and RNA-sequenced tags
reported in this paper is GSE43916. The accession numbers of publicly avail-
able data sets used in this study are reported in the Extended Experimental
Procedures.
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seven figures and can be found with this article online at http://dx.doi.org/
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